Gilgamesh Pharmaceuticals
Gilgamesh Pharmaceuticals is a pharmaceutical platform company developing an oral arylcyclohexylamine therapeutic and the next generation of psychedelic-related medicines.
1
Funding Rounds
$27.0m
Money raised
Overview
Gilgamesh Pharmaceuticals is a pharmaceutical platform company developing an oral arylcyclohexylamine therapeutic and the next generation of psychedelic-related medicines.
-
Website:
- Social accounts:
Funding series
Funding Series Analysis
The company Gilgamesh Pharmaceuticals has raised a total of $27m in funding over 1 rounds.
Key Insights:
- Gilgamesh Pharmaceuticals Series A round, May 2021: $27m
Gilgamesh Pharmaceuticals Series A round, May 2021
$27m
Industries
Gilgamesh Pharmaceuticals is active in the following industries: